




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
DendritcCells.DevelopmentMyeloidDCPlasmacytoidDC#NATUREREVIEWS|IMMUNOLOGYVOLUME12|APRIL2012.DendriticcellsPresenceofdangersignalsAdaptiveimmunityAntigenpresentationInnateimmunityAbsenceofdangersignalsImmunetolerance.DendriticcellsPresenceofdangersignalsAdaptiveimmunityAntigenpresentationInnateimmunityAbsenceofdangersignalsImmunetolerance.AntigenpresentationKubyImmunology6thedition.EndogenousantigenKubyImmunology6thedition.ExogenousantigenMHCIIInvariantchainCLIP(ClassII-associatedInvariantChainPeptide)HLA-DM和HLA-DOKubyImmunology6thedition.ActivationofTcellSignal1Signal2CytokinesKubyImmunology6thedition.DendriticCellsNotonlyantigenpresentation!.DendriticcellsPresenceofdangersignalsAdaptiveimmunityAntigenpresentationInnateimmunityAbsenceofdangersignalsImmunetolerance.InduceinnateimmunityIMMUNOBIOLOGYOFDENDRITICCELLSJacquesBanchereauetal.Annu.Rev.Immunol.2000.18:767–811.DendriticcellsPresenceofdangersignalsAdaptiveimmunityAntigenpresentationInnateimmunityAbsenceofdangersignalsImmunetolerance.Immunetolerance#JournalofCancerMolecules2(6):213-215,2006..DendriticcellsPresenceofdangersignalsAdaptiveimmunityAntigenpresentationInnateimmunityAbsenceofdangersignalsImmunetolerance.TumormicroenvironmentandDCsHotIssue.Convertdifferent
DCstomacrophage-likeDCs#Immunol.2013Nov25;4:403.CD14+macrophage-likeDCsPoorTcellstimulatoryabililitesTcellsuppressiveactivityCalledM2-typemacrophagesCD1c#Immunol.2013Nov25;4:403.CD14+macrophage-likeDCsCD14+DDC(dermaldendriticcell)PoorinducersofallogeneicTcellsRequirehighDC:TcellratiosforTh1inductionCarrylowlevelsofco-stimulatorymolecules.Convertmonocytetomacrophage-likeDCsIL-10,IL-6,orPGE2#Blood.
2011November17;
118(20):5498–5505..Convertfullydifferentiated
DCstomacrophage-likeDCsIL-10#JInvestDermatol.2011Feb;131(2):418-25.doi:10.1038..Convertfullydifferentiated
DCstomacrophage-likeDCsIL-10#IntJGynecolCancer2009;19:1487Y1493.Convertfullydifferentiated
DCstomacrophage-likeDCsIL-10#IntJGynecolCancer2009;19:1487Y1493.Convertdifferent
DCstomacrophage-likeDCs#Immunol.2013Nov25;4:403.Macrophage-likeDCssharesomestrikingtraitsReleaseofimmunosuppressiveIL-10(high)ExpressionofHIF1a,TGF-β,VEGFA,MMP3,MMP9,IL-8,andTNFaContributetotumor-promotingprocessesEndothelialcellmigrationandproliferationTumorgrowthandinvasion.Changesthatoccurinmyeloidcellsincancer#NATUREREVIEWS|IMMUNOLOGYVOLUME12|APRIL2012.SIGNALTRANSDUCTIONPATHWAYSACTINGASMASTER
SWITCHESOFTUMOR-INDUCEDDCSUPPRESSION.JAK2/STAT3signalingpathway.JAK/STATsignalingpathwayActivatedbyinterferon,interleukin,growthfactorsJAK:JanusKinaseSTAT:Signaltransducersandactivatorsoftranscription#Science296(5573):1653–5.doi:10.1126/science.1071545.JAK2/STAT3signalingpathway#NatRevCancer.2009Nov;9(11):798-809.doi:10.1038/nrc2734INDIRECTEVIDENCE.CombinedSTAT3andp38-MAPK
inhibitionwasrequired#OncoImmunology1:5,649–658;august2012.CombinedSTAT3andp38-MAPK
inhibitionwasrequired#OncoImmunology1:5,649–658;august2012DIRECTEVIDENCE!.MonocyteImmatureDCMatureDCM2Macrophage-likeDCIL-10pSTAT3p38IL-10IL-6PEG2pSTAT3IL-10IL-6PEG2IL-10IL-10,HIF1a,TGF-β,VEGFA,MMP3,MMP9,IL-8,andTNFapSTAT3p38pSTAT3p38pSTAT3p38.THERAPEUTICACTIVATIONJAK2/STAT3and/orp38-MAPKsignalinginterferenceLocalimmunepotentiationDC-stimulatoryagentsGM-CSF,IL4.Localimmunepotentiation#BLOOD,12APRIL2012,VOLUME119,NUMBER15.LocalimmunepotentiationGM-CSF,IL4StimulateT,Bcells#JImmunol2012;189:5223-5229.LocalimmunepotentiationGM-CSF,IL4Moreantibody#JImmunol2012;189:5223-5229.LocalimmunepotentiationTLR
agonists,suchasLPSCpGoligodeoxynucleotides.MonocyteImmatureDCMatureDCM2Macrophage-likeDCIL-10pSTAT3p38IL-10IL-6PEG2pSTAT3IL-10IL-6PEG2IL-10IL-10,HIF1a,TGF-β,VEGFA,MMP3,MMP9,IL-8,andTNFapSTAT3p38pSTAT3p38pSTAT3p38.ReferencevandeVenR,LindenbergJJ,OosterhoffD,etal.DendriticCellPlasticityinTumor-ConditionedSkin:CD14+CellsattheCross-RoadsofImmuneActivationandSuppression[J].Frontiersinimmunology,2013,4.BanchereauJ,BriereF,CauxC,etal.Immunobiologyofdendriticcells[J].Annualreviewofimmunology,2000,18(1):767-811.LiuKJ.Dendriticcell,toll-likereceptor,andtheimmunesystem[J].JCancerMol,2006,2:213.ObermajerN,MuthuswamyR,LesnockJ,etal.PositivefeedbackbetweenPGE2andCOX2redirectsthedifferentiationofhumandendriticcellstowardstablemyeloid-derivedsuppressorcells[J].Blood,2011,118(20):5498-5505.OuwehandK,OosterhoffD,BreetveldM,etal.Irritant-inducedmigrationofLangerhanscellscoincideswithanIL-10-dependentswitchtoamacrophage-likephenotype[J].JournalofInvestigativeDermatology,2010,131(2):418-425..ChenF,HouM,YeF,LvW,XieX.Ovariancancercellsinduceperipheralmaturedendriticcellstodifferentiateintomacrophagelikecellsinvitro.IntJGynecolCancer(2009)19:1487–93.doi:10.1111/IGC.0b013e3181bb70c6YuH,PardollD,JoveR.STATsincancerinflammationandimmunity:aleadingroleforSTAT3[J].NatureReviewsCancer,2009,9(11):798-809.OosterhoffD,LougheedS,vandeVenR,etal.Tumor-mediatedinhibitionofhumandendriticcelldifferentiationandfunctionisconsistentlycounteractedbycombinedp38MAPKandSTAT3inhibition[J].Oncoimmunology,2012,1(5):649-658.VuylstekeRJCLM,MolenkampBG,vanLeeuwenPAM,MeijerS,WijnandsPGJTB,HaanenJBAG,etal.Tumor-speci?cCD8+TcellreactivityinthesentinellymphnodeofGM-CSF-treatedstageImelanomapatientsisassociatedwithhighmyeloiddendriticcellcontent.ClinCancerRes(2006)12:2826–33.doi:10.1158/1078-0432.CCR-05-2431.ChuC-C,AliN,KaragiannisP,DiMeglioP,SkoweraA,Napolitan
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 展覽場地租賃合同
- 租賃小區(qū)場地合同
- 停薪留職合同協(xié)議
- 美術(shù)作品展覽權(quán)責免除合同
- 股份制企業(yè)合同簽署流程規(guī)范
- 環(huán)境咨詢服務合同
- 淘寶店裝修服務合同
- 養(yǎng)老服務合同發(fā)布
- 建筑工程質(zhì)量保證和監(jiān)理服務合同
- 南京師范大學中北學院《現(xiàn)代電力生產(chǎn)技術(shù)》2023-2024學年第二學期期末試卷
- 小學科學冀人版六年級下冊全冊同步練習含答案
- 郵政儲蓄銀行-客戶經(jīng)理(個人消費貸款)-試題+答案
- 2024年3月10日國考公務員稅務局面試真題及解析
- 旅店會客登記制度
- 市政造價員道路工程預決算入門講解(零起步培訓課件)
- VOC廢氣治理工程中低溫催化氧化技術(shù)的研究與實踐
- 《管理統(tǒng)計學》課件
- 工程力學期末考試試卷A及答案
- 教師的挑戰(zhàn):寧靜的課堂革命
- 新能源材料與器件導論緒論
- 市政工程監(jiān)理實施細則(完整版)
評論
0/150
提交評論